
Sign up to save your podcasts
Or
In this episode, Dr. Janine Rhoads interviews Dr. Mara Greenberg, an author of SMFM Consult Series #68 Sickle Cell Disease in Pregnancy. They delve into the challenges and opportunities for managing pregnant individuals with sickle cell disease. From pre-conception counseling to the importance of a multidisciplinary team approach, the discussion sheds light on optimizing outcomes for both mothers and newborns. Dr. Greenberg provides valuable insights into pain management and reproductive autonomy while emphasizing the importance of an equity-based approach in care delivery. Subscribe to the SMFM podcast series for more insightful discussions on maternal-fetal medicine.
Click here to access the SMFM Consult Series #68 Sickle Cell Disease in Pregnancy.
For the full transcript click here.
The 2024 U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC) provides updated recommendations for the use of specific contraceptive methods by persons who have certain medical conditions, including sickle cell disease. This page summarizes notable updates to the 2024 U.S. MEC and links to tools for providers.
4.7
2424 ratings
In this episode, Dr. Janine Rhoads interviews Dr. Mara Greenberg, an author of SMFM Consult Series #68 Sickle Cell Disease in Pregnancy. They delve into the challenges and opportunities for managing pregnant individuals with sickle cell disease. From pre-conception counseling to the importance of a multidisciplinary team approach, the discussion sheds light on optimizing outcomes for both mothers and newborns. Dr. Greenberg provides valuable insights into pain management and reproductive autonomy while emphasizing the importance of an equity-based approach in care delivery. Subscribe to the SMFM podcast series for more insightful discussions on maternal-fetal medicine.
Click here to access the SMFM Consult Series #68 Sickle Cell Disease in Pregnancy.
For the full transcript click here.
The 2024 U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC) provides updated recommendations for the use of specific contraceptive methods by persons who have certain medical conditions, including sickle cell disease. This page summarizes notable updates to the 2024 U.S. MEC and links to tools for providers.
91,011 Listeners
60 Listeners
7,701 Listeners
43,483 Listeners
8,873 Listeners
12,553 Listeners
3,336 Listeners
111,917 Listeners
56,285 Listeners
433 Listeners
4,314 Listeners
203 Listeners
41,504 Listeners
363 Listeners
1,144 Listeners